Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

For the first time, large language models performed on a par with gold medallists in the International Mathematical Olympiad.

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

July 21 (Reuters) - Alphabet's (GOOGL.O) Google and OpenAI said their artificial-intelligence models won gold medals at a ...

Google DeepMind’s Gemini and OpenAI’s ChatGPT achieved gold medal-level scores at the 2025 International Mathematical ...